Progesterone and its metabolites as therapeutic targets in psychiatric disorders

Author： Bristot Giovana   Ascoli Bruna   Gubert Carolina   Panizzutti Bruna   Kapczinski Flávio   Rosa Adriane R  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.18, Iss.6, 2014-06, pp. : 679-690

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Therapeutic Effects of Progesterone in Animal Models of Neurological Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 8, 2013-12 ,pp. : 1205-1218

Bentham Science Publishers

Access to resources Recommend Favorite

Neuropeptides as Therapeutic Targets in Anxiety Disorders

By  

Current Pharmaceutical Design, Vol. 18, Iss. 35, 2012-12 ,pp. : 5709-5727

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroplasticity and its Relevance to Psychiatric Disorders

By Singh Vijender   Garg Bhavuk  

Current Psychopharmacology, Vol. 3, Iss. 3, 2014-12 ,pp. : 151-157

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroplasticity and its Relevance to Psychiatric Disorders

By  

Current Psychopharmacology, Vol. 3, Iss. 3, 2014-12 ,pp. : 151-157

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroinflammation: A Therapeutic Target of Cotinine for the Treatment of Psychiatric Disorders?

By  

Current Pharmaceutical Design, Vol. 22, Iss. 10, 2016-03 ,pp. : 1324-1333

Bentham Science Publishers

Access to resources Recommend Favorite